App-Based rehab after cancer surgery shows promise in small study
NCT ID NCT05406024
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a digital platform designed to help patients recover physically and mentally after major surgery for esophageal or laryngeal cancer. The platform offered short daily exercise sessions. The study included 30 patients and focused on whether they would use the tool and find it acceptable. It was a small feasibility study, so it cannot yet prove the platform improves recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- digital platform with exercise sessions
- What this could lead to
- If this approach works, it could offer a convenient way for patients to recover at home after major cancer surgery, improving their quality of life.
- What could go wrong
- This was a very small feasibility study with only 30 participants, so results may not apply to everyone. It only measured if patients used the platform, not whether it actually improved health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
30 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
Apr 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients hospitalized for surgical management of esophageal or laryngeal cancer in Lille University Hospital
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Hospitalized for initial surgical management of esophageal or laryngeal cancer * Admitted to a conventional ward after partial oesophagectomy or total laryngectomy in a neoplastic setting * Patient giving consent to participate in the study * Affiliated to the compulsory health insurance scheme, regardless of the scheme Exclusion Criteria: * Patient who did not follow the previously described course of care prior to admission to the ward * Esophagectomy with total circular pharyngo-laryngectomy * Total esogastrectomy * Illiterate, visually impaired patient * Minor, or adult under guardianship or curatorship, under judicial protection, person deprived of liberty
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Esophageal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universtaire
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood proteins may predict who beats esophageal cancer with chemoradiation
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers
- Can a direct hit to tumors make immunotherapy work better?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Can a guided missile for chemo hit tumors harder and spare healthy tissue?
- Can a new drug shrink tumors that resist standard care?